MedPath

Feasibility and Acceptability of the Technology Based Enhanced Gender Support Platform Implementation With Parents

Not Applicable
Not yet recruiting
Conditions
Parents
Usability
Registration Number
NCT07022392
Lead Sponsor
Seattle Children's Hospital
Brief Summary

This is a small pilot feasibility and acceptability study of implementing a Technology-Enhanced Gender Support (TEGS) platform with parents and caregivers. Parents and caregivers who consent to participate will complete an electronic survey at baseline. They will then receive access to the TEGS platform and complete follow up surveys 1 mo and 3 mo after. Each participant will also be given the option to participate in an exit interview.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Parent of a gender diverse youth aged 8-17
  • Has access to the internet
  • Can speak or read English
Exclusion Criteria
  • Not a parent of a gender diverse youth aged 8-17
  • No access to the internet
  • Cannot speak or read in English

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
System Usability Scale1 month and 3 months

10 item measure of intervention usability measured on a scale from 0 to 100 with 100 indicating higher usability

Secondary Outcome Measures
NameTimeMethod
Transgender Family Acceptance To Empowerment scaleBaseline, 1 month, 3 month

16 item measure of parental acceptance and empowerment, measured on a scale of 0 to 80 with 80 indicating a better outcome

Trial Locations

Locations (1)

Seattle Children's Hospital

🇺🇸

Seattle, Washington, United States

Seattle Children's Hospital
🇺🇸Seattle, Washington, United States
Gina Sequeira, MD, MS
Principal Investigator
Laura Richardson, MD, MPH
Contact
206-987-2028
laura.richardson@seattlechildrens.org

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.